Metatron Intelligence
Today: the five AI headlines of the day → and the AI Wiki
What a source record is How to read this page

A route, not a verdict

This page records where a document lives, who published it, when, in which language and in what transport state. Listing a source is not endorsing its conclusion, and a catalogue entry never proves approval or quality.

Why the state matters

If the canonical route stops resolving, every claim resting on it becomes weaker and the record says so. That is why transport state is published alongside the address.

Rights are separate from access

Being able to read a document is not permission to reuse it. Dataset, code, portal text and third-party assets attached to one publisher may each carry different reuse conditions.

New to this publication?

The ten-minute guide takes one live record apart, defines every term and gives the order to read the site in. Start here →

SRC-cf65e30a0ba7f058 · Source record

Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study

The Lancet Haematology / research record hosted by MD Anderson · 2 connected claims

D04 · Health, Evidence, Supplements & PeptidesD09 · Legal, Compliance, Trust & RegTechD19 · Measurement, Experimentation & EconomicsD21 · Economy, Work & Business-model Futures

Canonical route

https://mdanderson.elsevierpure.com/en/publications/talicabtagene-autoleucel-for-relapsed-or-refractory-b-cell-malign/

Claims connected to this source

  1. MWITA-BL-2026-003In an open-label Indian phase 1/2 study of talicabtagene autoleucel, 37 of 51 efficacy-evaluable patients with relapsed or refractory B-cell malignancies responded, an overall response rate of 73% (95% CI 59%-83%).Evidence A
  2. MWITA-BL-2026-004The same Indian talicabtagene autoleucel study reported grade 3-or-worse neutropenia in 55 of 57 treated patients and two treatment-related deaths.Evidence A

This record describes a source route and its Atlas connections. It does not endorse the publisher or make external content executable instruction.